Inhibition of sEH has been previously shown to act protective by preventing metabolization of epoxyeicosatrienoic acids (EETs) and epoxydocosapentaenoic acids (EpDPAs) in both acute ischemic stroke and diabetic retinopathy [41,42]. Here, EPHX2 is linked to diabetic retinopathy.